| アブストラクト | Background: Interleukin 17 (IL-17) inhibitors provide an excellent treatment option for patients with psoriasis and psoriatic arthritis, resulting in high levels of efficacy for skin clearance and joint improvement. Safety has also been established in clinical trials for this group of biologic agents; however, rare case reports of exacerbation or induction of inflammatory bowel disease (IBD) have been reported in the literature. No causal relationship has been established. When IL-17 inhibitors were investigated for the management of IBD, no benefit was found and worsening of disease was noted for some patients. IBD is more common in patients with psoriasis and, therefore, it remains unknown if these drugs cause de novo IBD or if the reported cases of IBD in patients on IL-17 therapy is due to the background risk in this predisposed population who may have already had an underlying or subclinical disease. Methods/Results: A literature search was conducted for the terms 'IL-17 inhibitor,' 'ixekizumab,' 'secukinumab,' 'brodalumab' and 'inflammatory bowel disease,' 'ulcerative colitis,' and 'Crohn's disease' in PubMed and Google Scholar. Cases of new-onset or exacerbation of IBD were identified in the literature along with postmarketing pharmacovigilance data. These cases will be reviewed in this paper. Conclusions: IL-17 inhibitors have proven efficacy for the treatment of psoriasis and psoriatic arthritis with a strong safety profile. However, rare cases of IBD onset and exacerbation in patients on IL-17 inhibitors have been reported in the literature, highlighting the need to select patients and therapeutic choices appropriately when treating this population. |
|---|
| ジャーナル名 | Drugs in context |
|---|
| Pubmed追加日 | 2020/5/5 |
|---|
| 投稿者 | Fieldhouse, Keira A; Ukaibe, Samantha; Crowley, Erika L; Khanna, Reena; O'Toole, Ashley; Gooderham, Melinda J |
|---|
| 組織名 | SKiN Centre for Dermatology, 775 Monaghan Road South, Peterborough, ON K9J 5K2,;Canada.;Trent University, 1600 W Bank Dr, Peterborough, ON K9J 0G2, Canada.;University of Western Ontario, London, ON N6A 3K7, Canada.;Probity Medical Research, 139 Union St E, Waterloo, ON N2J 1C4, Canada.;Queen's University, 99 University Ave, Kingston, ON K7L 3N6, Canada. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/32362930/ |
|---|
